BiotechTubeBiotechTube
Home/Compugen/Eran Ophir
EO

Eran Ophir

Chief Scientific Officer

Compugen

Therapeutic Areas

OncologyImmuno-oncology

Compugen Pipeline

DrugIndicationPhase
COM701 (anti-PVRIG)Advanced solid tumorsPhase 1/2
COM902 (anti-TIGIT)Advanced solid tumorsPhase 1
Bispecific Antibody ProgramsUndisclosed cancersPreclinical

Leadership Team at Compugen

AC
Anat Cohen-Dayag
Chief Executive Officer
HA
Henry Adewoye
Chief Financial Officer
MZ
Maytal Ziv
Chief Medical Officer
View full Compugen profile